Germany Medical Cannabis Imports Top 200 Tonnes in 2025
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the second time in a year.
The latest medical cannabis import figures from BfArM, covering the final quarter of 2025, show that the post-CanG boom may finally be slowing after consecutive periods of high double-digit growth.
Despite nearly tripling 2024’s total of 72 tonnes over the year, Q4 imports fell to 58,794kg, down 2,738 kg (-4.45%) from Q3’s record of 61,532kg.
While this fall in imports is relatively minimal, it is in stark contrast to the runaway growth seen throughout the last three quarters, seeing imports grow 15%, 16%, and 42% respectively.
As we have covered repeatedly over the last year, the German market is heading into a period of oversaturation, while efforts to curb the medical cannabis industry in the Bundestag are ongoing.
It’s possible these figures could be the first signs that these factors are starting impact the market, but it’s critical to note that an even more pronounced import drop happened in Q4, 2024, when imports fell from 40 tonnes to 32 tonnes sequentially, following a similar run of explosive growth.
As such, it’s unlikely we’ll have the full picture until Q1, 2026 figures are available.
What the Q4 data shows
Canada retained its position as Germany’s dominant supplier, but shipments fell 11% from Q3’s 30,073 kg to 26,769 kg in Q4, the first quarterly decline for the country in over a year. For the full year, Canada exported 93,006 kg to Germany, representing 46% of total imports and cementing its role as the single most important supplier in the global medical cannabis trade.
Prohibition Partners’ senior analyst Lawrence Purkiss noted: “Looking at German import statistics over the full year, it is clear that in 2025, Canada has pulled even further ahead as the leading source of medical cannabis supply globally. While Portugal also represents significant volumes, we estimate that the majority of shipments from Portugal also originate from Canadian cultivation.
“This new data reflects the same picture we are seeing elsewhere: while supply from new sources continues to grow, this new supply is far outpaced by the growth of Canada’s exports.”
Portugal, Germany’s leading European supplier, also contracted in Q4, falling 21% from 16,552 kg to 13,088 kg. Over the full year, Portugal shipped 55,164 kg, consolidating its position as Europe’s primary cannabis export hub, though its share of the German market appears to have peaked. Together, Canada and Portugal accounted for 68% of Germany’s Q4 imports, down from approximately 77% in Q3, suggesting a gradual broadening of the supply base.
The supply diversification story is most visible among smaller exporters. The Czech Republic posted the most dramatic swing of the quarter, rising from just 441 kg in Q3 to 2,983 kg in Q4, a 576% increase that elevates it to one of Germany’s top five suppliers for the first time.
Australia also recorded a strong quarter, more than tripling its shipments from 625 kg to 2,122 kg (+240%), a performance that may reflect both growing export capacity and deliberate stockpiling by German importers ahead of anticipated restrictions.
Colombia continued its recovery, rising from 1,175 kg to 1,873 kg (+59%), while the United Kingdom increased exports to 1,509 kg, its highest quarterly figure on record. The Netherlands posted a 42% rise to 644 kg, and South Africa grew 24% to 1,370 kg. Spain, however, fell sharply, down 51% to 991 kg after a strong Q3 showing, while Lesotho contracted 45% to 148 kg.
Alex Khourdaji, also a Senior Analyst at Prohibition Partners, added: “Germany’s medical cannabis imports serve as a clear indicator of the growth of the international medical cannabis industry. These imports reflect the establishment of stronger supply chains, particularly from previously smaller exporters like the UK (primarily Jersey) and Colombia, whose exports to Germany have increased by 11x and 5.4x, respectively, compared to 2024.
In addition, Australia, which exported a total of 3.3 tonnes of medical cannabis globally in 2024, exported over 4.1 tonnes to Germany alone in 2025. This indicates that Australia is increasingly utilising its domestically cultivated medical cannabis for the export market. North Macedonia, which in 2024 saw its German imports increase 2.8x, witnessed another explosive growth year, with its country’s exports reaching 8.1 tonnes, a threefold increase compared to 2024, showing strong signs of the country’s production capabilities.
